---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-018189"
form_type: "8-K"
ticker: "ELAB"
cik: "0001840563"
company_name: "PMGC Holdings Inc."
filed_at: "2026-02-19T23:59:59+00:00"
generated_at: "2026-05-16T01:48:31.045105+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# PMGC subsidiary files 10 US patent applications for EL-22/EL-32 in animal muscle growth

## Summary
- NorthStrive Biosciences, wholly owned by PMGC, filed ten US patent applications expanding EL-22 and EL-32 into animal health and agriculture.
- Applications cover EL-22 (5 patents) and EL-32 (5 patents) for livestock, aquaculture, and poultry including muscle growth and yield.
- Two applications target livestock muscle growth: EL-22 (19/541,209) and EL-32 (19/540,888).
- Additional filings address emissions reduction in livestock and aquaculture, and poultry muscle development.
- This expands PMGC's IP portfolio beyond human aesthetic medicine into animal agriculture markets.

## SEC filing metadata
- accession: 0001213900-26-018189
- form_type: 8-K
- ticker: ELAB
- cik: 0001840563
- company_name: PMGC Holdings Inc.
- filed_at: 2026-02-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840563/000121390026018189/0001213900-26-018189-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840563/000121390026018189/ea0277555-8k_pmgc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-018189
- JSON: https://secwatch.observer/filing/0001213900-26-018189.json
- Plain text: https://secwatch.observer/filing/0001213900-26-018189.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.